The Impact Of Dietary Phytase Supplementation On Skeletal Biomechanics And Characteristics In Growing Swine And Mice by Faber, Catherine
THE IMPACT OF DIETARY PHYTASE SUPPLEMENTATION ON 
SKELETAL BIOMECHANICS AND CHARACTERISTICS IN GROWING 
SWINE AND MICE  
 
 
 
 
 
A Thesis 
Presented to the Faculty of the Graduate School 
of Cornell University 
in Partial Fulfillment of the Requirements for the Degree of 
Master of Science  
 
 
 
 
 
by 
Catherine Ann Faber 
August 2009
  
 
 
 
 
 
 
 
 
 
 
© 2009 Catherine Ann Faber 
ABSTRACT 
 
The misconception that bone is a static tissue underestimates its importance in 
human and animal health, as well as the many factors that influence its 
development and maintenance. Genetic, hormonal, mechanical and nutritional 
factors all influence bone strength and mass, particularly in early life. 
Musculoskeletal diseases, such as osteochondrosis and osteoporosis, are 
debilitating to humans and animals and create a substantial financial burden 
on the country’s health care system and food animal production industries. 
Efforts to discover strategies for the prevention and management of 
musculoskeletal diseases have become a major area of research.  
 
Our research examined the impact of nutritional supplementation on bone 
strength and mass as a means to improve bone integrity early in life and 
reduce the susceptibility of the skeleton to musculoskeletal diseases. Phytase, 
an acid phosphatase, was the primary dietary supplement examined because 
it improves bone strength in swine, broiler chicks and rats fed a phosphorus 
deficient diet. We were interested in the ability of phytase to improve bone 
strength in young animals through a non-phosphorus mechanism. Therefore, 
we conducted a series of feeding trials in swine (Yorkshire x Hampshire x 
Laundrace) and mice (129/SVJ×C57BL/6 line) fed phosphorus adequate diets. 
In addition, two other bone-impacting dietary supplements, inulin and 
strontium, were examined as well. These two additional supplements were 
examined with phytase because studies have suggested that they might have 
an additive effect and further improve bone strength and mass when 
supplemented with phytase.  
 In swine, phytase supplementation for 5 weeks in a nutrient adequate diet 
increased (p < 0.05) femur bending rigidity and mineral content. When 
phytase was supplemented in the diet with inulin or strontium, no significant 
impact on skeletal tissue was observed. Dietary inulin supplementation alone 
for 5 weeks altered (p < 0.05) the ellipticity index of femurs and dietary 
strontium supplementation alone for 10 weeks increased (p < 0.05) femur 
mineral density.  
 
In the mouse, we did not observe an impact of phytase supplementation on 
skeletal functional parameter, such as femur breaking strength or bending 
rigidity, when its substrate, phytate, was absent from the nutrient adequate 
diet. Superoxide dismutase knockout mice (SOD1 -/-; Cu, Zn-SOD; EC 
1.15.1.1) provided an animal model with a compromised skeletal system. 
Phytase supplementation was not effective in improving breaking strength or 
bending rigidity in this model.  
 
Our results suggest that phytase supplementation has some beneficial effects 
on bone breaking strength early in development when supplemented in a diet 
with its native substrate. Phytase supplemented with either inulin or 
strontium did not provide any additional benefit on bone parameters 
examined in these studies. 
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CHAPTER ONE 
INTRODUCTION 
1.1 The Skeleton 
 
1.1.1 Composition 
 
Skeletal tissue is a specialized form of connective tissue that serves two main 
functions. Bone provides internal structural support and acts as a mineral 
reservoir, particularly for essential elements such as calcium and phosphorus 
(1,2). Bone consists of bone cells, vessels, and a matrix of collagen and 
minerals (1). Collagen gives bone flexibility and also provides a surface for the 
nucleation of bone mineral crystals. Hydroxyapatite crystals, Ca10(PO4)6(OH)2, 
are the predominant type of mineral in bone but these crystals have a 
tendency to absorb and substitute other minerals into their lattice structure, 
such as fluoride or strontium (3).  
 
Bone is composed of two tissue structures, cortical and cancellous, that are 
classified by their porosity, or volume fraction of bone tissue (3).  Cancellous, 
or trabecular, bone has a porosity of approximately 75-95%. The cancellous 
bone matrix consists of plates or structs, known as trabeculae, each 
approximately 200 µm thick. The cavities between these trabeculae are filled 
with bone marrow. On the other hand, cortical, or compact bone, is quite 
dense with a porosity of 5-10% and is located in long bones, forming a shell 
around cancellous bone (4). Cortical bone is intercalated with Haversian 
canals and Volkmann’s canals. The former contains capillaries and nerves 
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aligned with the long axis of the bone, while the latter are transverse and 
connect Haversian canals to each other and to the outside surface of the bone. 
Volkmann’s canals are shorter than Haversian canals, but also contain blood 
vessels and nerves (Fig. 1.1) (3).  
 
 
 
 
 
 
 
 
 
Figure 1.1  A schematic demonstration of a cross and longitudinal section of 
the femur diaphysis. Modified from Seeley, R. R., Stephens, T. D. & Tate, P. 
(Eds). (2007). Anatomy and Physiology. McGraw-Hill Science. 
 
1.1.2 Bone Remodeling 
 
Bone is not a static structure and is continuously undergoing a remodeling 
process to repair microfractures and modify skeletal areas in response to 
biomechanical and hormonal signals (1). Remodeling involves the destruction 
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and absorption of mineralized bone followed by the deposition of new bone, 
thereby preserving the structure and function of the skeleton (5). Two distinct 
types of bone cells are responsible for the remodeling process of the 
mineralized extracellular matrix: osteoclasts and osteoblasts (2). Osteoclasts 
catabolize bone by acidification and proteolysis of the bone matrix. The 
resulting cavity is filled by recruited osteoblasts, which deposit the new bone 
matrix in two steps. First, osteoblasts produce osteoid, an unmineralized 
organic matrix of bone comprised of collagen and noncollagenous proteins, 
proteoglycans, and water (5).  After deposition of the osteoid, osteoblasts 
direct mineralization of the osteoid and mineral is deposited within and 
between the collagen fibers. During the remodeling process, osteoclasts and 
osteoblast are coupled together and work as a team called the basic 
multicelluar unit (BMU) (3). As described above, the BMU remodeling 
sequence follows a characteristic order initiated with activation (precursors 
cells signaled to differentiate), resorption and formation, or the A-R-F 
sequence.  
 
1.1.3 Endochondral Ossification 
 
The longitudinal growth of bones is accomplished by endochondral 
ossification, the replacement of cartilage by bone tissue during skeletal 
maturation (3). The prenatal skeleton is composed of cartilaginous structures, 
which act as a template for ossification (Fig 1.2) (6). Prior to partition, 
ossification occurs at the center of the bone shaft, or diaphysis, forming the
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Figure 1.2  Scheme of endochondral ossification in a long bone. An approximate time-line in shown below the 
images to represent when the changes bone structure are occurring in the developing animal. Modified from 
Buckwalter, J. A., Thomas A., M. D. E. & Simon, S. R. (2000). Skeletal Function and Form: Mechanobiology of Skeletal 
Development, Aging and Regeneration. Cambridge University Press.  
Cartilage 
model 
Fig. 1.3 
Postnatal Prenatal Birth 
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primary ossification center (POC). The initiation of the POC results from 
morphological changes of cartilages cells, or chondrocytes in this area (6) 
 
Chondrocytes begin to enlarge and end their secretion of collagen 
andproteoglycans, components of the extracellular matrix (7). Thus, instead of 
contributing to the ECM, chrondrocytes initiate the calcification of the matrix 
via secretion of alkaline phosphatase. In addition, chrondrocytes secrete 
vascular endothelial cell growth factor (VEGF), a growth factor involved in 
recruiting blood vessel (7). Blood vessels supply the POC with nutrients as 
well as provide a route for the migration of other cell types, such as 
osteoblasts. Chondroblasts, osteoclast-like cells, are responsible for 
catabolizing the calcified cartilage, while osteoblast subsequently lay down 
new bone (3). Remodeling activity begins to convert calcified cartilage to bone.  
 
At about the time of partition, a secondary ossification center originates in the 
center of the epiphysis, which partially divides the epiphyseal growth 
cartilage into the epiphyseal plate and articular cartilage (6). Endochondral 
ossification occurs at both of these sites and involves the proliferation, 
degeneration, and apoptosis of the chondrocytes followed by the calcification 
and ossification of the matrix to increase bone length and size (7,8). The 
epiphyseal plate is divided into zones representing the life cycle of 
chrondrocytes and includes the resting, proliferative, hypertrophic, and 
calcification zones (Fig. 1.3) (3). These zones are similar to the morphological 
transformations of chrondroytes described in the POC, but are arranged in a 
vertical pattern in the epiphyseal cartilage that allows the bone to grow in 
  6 
Figure 1.3  Enlargement of epiphyseal plate and articular cartilage of a long 
bone.  At both sites, chondrocytes undergo a series of morphological 
changes, which leads to the calcification of cartilage. Osteoclast and 
osteoblast cells work together to replace the calcified cartilage with bone. 
Modified from Liem, K., Bemis, W., Walker, W. F. & Grande, L. (2003). 
Functional Anatomy of the Vertebrates: An Evolutionary Perspective. Brooks Cole. 
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length. The resting zone is nearest the epiphyseal side of the epiphyseal plate 
and contains stems cells that differentiate into chondrocytes. In the 
proliferative zone, chondrocytes divide rapidly and produce molecules that 
build the surrounding ECM. Mature chondrocytes no longer proliferate, but 
increase in size (9). In the hypertropic zone, mature chondrocytes stop 
contributing to the ECM and begin to calcify the matrix. Mature chondrocytes 
in the zone of calcification degenerate and die as a result of apoptosis (3). A 
calcified matrix remains and is replaced by bone through the action of 
chondroclasts and osteoblasts, and further remodeling activity (3). 
Endochondral ossification also occurs in the articular cartilage, or the 
articular-epiphyseal cartilage (AECC), to increase bone size and achieve the 
adult form (7,8,10). When skeletal maturation is complete and bones are of 
adult length, the epiphyseal plate is no longer needed and is ossified. 
Ossification of the epiphyseal plate connects the epiphysis to the metaphysis 
and also unites the blood circulatory system (3). 
 
1.2 Musculoskeletal diseases 
 
Musculoskeletal diseases are diseases of the muscles, associated ligaments, 
bones and cartilage. Alterations in normal bone development and 
maintenance can interfere with skeletal function, leading to musculoskeletal 
disease and abnormalities. A number of factors impact bone health, such as 
genetics, hormones, nutrition, and mechanical loading and are particularly 
influential during skeletal maturation (11). Therefore, creating an optimal 
environment for the skeletally maturating animal is a strategy for maximizing 
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bone health and possibly reducing the risk of musculoskeletal diseases. 
Osteochondrosis and osteoporosis are two musculoskeletal diseases that are 
particularly debilitating to a number of species and create a financial burden 
on society.  
 
1.2.1 Osteochondrosis 
 
Osteochondrosis is a developmental orthopedic disease (DOD), a 
musculoskeletal disease that occurs in the growing animal (12). 
Osteochondrosis (OC) occurs in a number of species including humans, but 
mostly commonly affects domesticated animals, such as pigs, lambs, cattle, 
horses, and large dogs (7,13-16). These rapidly growing animals display 
clinical signs of osteochondrosis in adolescence with the disease becoming 
more detrimental as the animal ages. Clinical signs include leg weakness 
syndrome, or abnormal ambulation, joint stiffness, and degrees of lameness 
are usually observed with osteochondrosis, while limb deformities are 
possible but less frequent (17).  
 
Osteochondrosis is a focal disturbance in endochondral ossification of long 
bones at either the epiphyseal plate or the immature articular-epiphyseal 
cartilage (18). An area of growth cartilage fails to differentiate and calcify, 
delaying endochondral ossification, a hallmark of OC. As a consequence, 
cartilage accumulates at the expense of bone and the deepest layers of 
cartilage are sequestered from nutrients (19). Cartilage relies on the diffusion
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Figure 1.4  (A) Zonal nature of chondrocytes in the growth cartilage at the articular-epiphyseal complex. (B) 
Representation of an osteochondrotic lesion formed in the growth cartilage. Modified from Bonjour et al., 2009. 
 
A. 
 
B. 
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of nutrients from synovial fluid in the joint cavity because blood vessels are 
absent from the uncalcified cartilage matrix (12). The thickened cartilage 
reduces cartilage nutrition and creates localized ischemic, which lead to the 
necrosis of the cartilage. Endochondral ossification fails when the ossification 
front reaches the necrotic area and remodeling activity is unable to convert 
uncalcified cartilage to bone (Fig. 1.4) (10).   
 
A lesion in immature cartilage is a clinical sign of OC and is formed from 
necrotic cartilage and debris (10). Lesions at the articular-epiphyseal cartilage 
disrupt normal joint movement while those at the epiphyseal plate disrupt 
longitudinal growth and may alter the entire shape of the bone. Lesions 
weaken the bone area leading to fissures in the cartilage (19). At the articular 
surface, cartilage that forms the lesion can fragment allowing debris to enter 
into the joint space, creating painful swollen joints. Furthermore, mechanical 
loading can exacerbate the size of fissures, creating cartilage flaps, 
perpetuating joint inflammation (19). The cartilage flaps may completely 
separate from the epiphysis and form loose bodies, or joint mice, in the joint 
cavity, creating a painful peddle-in-shoe effect (10). 
 
The prevalence of osteochondrosis in a variety of domesticated animals has 
become an animal welfare concern. Furthermore, this disease is responsible 
for major economic losses in both the equine and livestock industry due to the 
culling of breeding animals and carcass condemnations of affected animals 
(16,17). Therefore, OC prevention is essential to human and animal well-being 
and it is necessary to mitigate economic losses in food animal production and 
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equine industries. However, the etiology of osteochondrosis is multifactorial 
and includes rapid growth rate, anatomical characteristics, genetics, nutrition 
and weak cartilage and bone structure (13). In food animal production, as well 
as in the equine industry, animals are selected and bred for rapid growth to 
maximize economic efficiency and production. Rapid weight gain in young 
growing animals is an additional challenge for the maturing skeleton and may 
increase the risk of osteochondrosis (13). For example, an increase in growth 
rate in dogs coincides with skeletal diseases, like osteochondrosis (20). Larger 
dogs were shown to have a less dense epiphyseal bone below the articular 
cartilage. The lower density of bone in large dog suggests that the skeleton is 
less strong and may increase the risk for osteochondrosis (20).  Therefore, 
strategies to optimize bone characteristics, such as mass and strength, in the 
developing animal may aid in the prevention of osteochondrosis.  
 
1.2.2 Osteoporosis  
 
Osteoporosis is a musculoskeletal disease that is characterized by 
compromised bone strength, which leads to an increase risk in fracture (21). 
More than 10 million people in the United States suffer from this disease, 
resulting in approximately 300,000 hip fractures, 700,000 spinal fractures, 
250,000 wrist fractures, and 300,000 fractures at other sites annually (22).  
Osteoporosis is prevalent among the elderly population and is the result of the 
overall weakening of the skeleton with age. Bone loss is a normal part of the 
remodeling cycle, however it plays a more dominant role in the aging 
individual. The shift in the remodeling cycle to favor bone loss along with a 
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number of factors, such as genetic, hormonal, gender, and nutritional 
contribute to the onset of osteoporosis (21). 
 
Osteoporosis also affects a number of domesticated animals, such as cattle, 
pigs, and poultry (17,23,24). Breeding production animals are most susceptible 
to the disease during lactation when calcium is in high demand for milk 
production and is mobilized from bones. Sows in late gestation and during 
lactation have particularly weak bones that are vulnerable to fractures (17). 
Furthermore, sows have little time to recover skeletal mass between breeding 
cycles which progressively deteriorates the skeleton, causing a considerable 
numbers of sows to be culled due to fractures and lameness (25). In addition, 
osteoporotic fractures are a major cause of mortality in high-production 
poultry flocks (24). A progressive loss of structural bone in laying hens is due 
to shift in the remodeling cycle, but exacerbated by the relative inactivity of-
caged bird. Such osteoporotic fractures are costly to the swine and poultry 
industry and are an animal welfare concern. 
 
In both humans and animals, osteoporosis is a common musculoskeletal 
disease that is debilitating to the affected individual and creates a financial 
burden on the health care system and food animal production industries. 
Fortunately, research has suggested that this disease is largely preventable by 
optimizing bone strength and mass early in life and maintaining it throughout 
the lifespan of the organism (26). Growth in bone size and strength occurs 
early in life, but the accumulation of bone mass is not complete until the third 
decade of life in humans and around eighteen months in pigs (25,26). 
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Currently, there is no accurate noninvasive measurement for overall bone 
strength so bone mineral density (BMD) is frequently used as a proxy 
measure, and accounts for approximately 70 percent of bone strength (26). 
Individuals with high BMD, suggesting high bone mass and strength, after 
adolescence have the greatest protective advantage when the inexorable 
decline in bone density associated with increasing age, illness, and diminished 
sex-steroid production take their toll (11,27).  Bone strength and mass attained 
early are perhaps the most important determinant of life-long skeletal health 
(26).   
 
1.3 Potential Dietary Supplements to Improve Whole Bone Strength  
 
A number of factors influence bone strength in children and young animals 
such as, genetics, mechanical loading, hormones, and nutrition (Fig. 1.5) (11). 
Nutrition status directly affects bone health and is essential for proper skeletal 
development and maintenance (26). Because nutrition is a modifiable factor 
that affects bone, it is one approach for increasing bone strength and mass 
early in life. Our research investigated three potential dietary supplements for 
increasing bone strength and mass in young animals as a means to decrease 
the risk of musculoskeletal diseases, like osteochondrosis and osteoporosis.. 
The dietary supplements investigated were phytase, inulin, and strontium, 
which have all been shown to have potential benefits in improving bone 
integrity and strength when supplemented in the diet in a variety of species 
(26,28,29).  
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 Figure 1.5  Factors that influence whole bone strength. Modified from Bonjour et al., 2009. 
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1.3.1 Phytase 
 
Phytic acid, or myo-inositol hexakisphosphate, is an essential compound for 
phosphorus and mineral storage in plants (30,31). Cereal grains, such as 
wheat, corn, rice and soybean meal, and legume plants, particularly grasses, 
are major sources of phytic acid (31). Phytic acid contains negatively charged 
phosphate groups, which spontaneously bind to multivalent cations, 
particularly elements like calcium, iron, and zinc (30,32). As a mixed cation 
salt, the phytic acid compound is referred to as phytate, or more specifically 
phytin when bound to calcium and magnesium ions (31,33). Phytate is 
degraded by phytase, a phosphohydrolase present in plants and bacteria. 
Phytase catalyzes the removal of orthophosphates and minerals from the 
phytate (Figure 1.6) (34). 
 
1.3.1.1 Phytase in Agriculture  
 
Livestock feed is primarily composed of corn and soybean-meal and as a 
result 60 to 75 percent of the phosphorus is organically bound in the form of 
phytate (30). Ruminants possess bacteria in their gastrointestinal tract that 
produce sufficient quantities of phytase to utilize the phosphorus and mineral 
contained in phytate (35). Other livestock animals, such as pigs, poultry and 
fish, do not possess phytase in sufficient amounts and are unable to break 
down phytate in the plant-based diet (36). In nature, simple-stomached 
animals are able to obtain phosphorus from primary sources that contain 
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Phytate 
(substrate) 
Phytase 
(enzyme) 
+ 
Inorganic Phosphorus 
(iP) 
Inositol Phosphates 
Minerals 
(i.e., Ca, Mg, Zn, Fe) 
Figure 1.6  Degradation of phytate by phytase. Phytase catabolizes phytate yielding inorganic phosphate, mineral 
cations, and inositol phosphates.  
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endogenous phytase, however plant-based feeds destined for agricultural use 
are highly heat-treated during processing and plant phytases may be 
inactivated. Thus, the plant-based feed used in agricultural practices contains 
phosphorus in phytate form with limited endogenous phytase, leading to 
substantial phosphorus and minerals being unavailable to the monogastric 
animals. 
 
1.3.1.2 Nutritional and Ecological Effects 
 
The inability of monogastric organisms to utilize the naturally occurring 
phytate in feed is of agricultural and ecological concern. First, the diets of 
monogastic animals must be supplemented with a non-phytate form of 
phosphorus, like inorganic phosphorus (iP), in order for the animal to receive 
sufficient levels of phosphorus and achieve proper growth (34,35,37). 
Inorganic phosphorus is expensive and a limitied resource (35). Secondly, the 
feces of monogastic animals contain large amounts of non-digested phytate 
and unabsorbed phosphorus. The unabsorped phosphorus is due to the 
presence of a phytase-producing microbes in the colon of monogastric 
animals. However, P and cations liberated from phytae by microbal phytases 
are poorly absorbed in the colon and the majority is excreted. Large amounts 
of phosphorus are released into the environment and can lead to the 
damaging natural ecosystems such as eutrophication in aquatic habitats 
(32,35). Therefore, interest in supplementing the diets of monogastric livestock 
with phytases engineered to have high activity early in the gastrointestinal 
tract as a potential means for increasing essential mineral bioavailability in 
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livestock diet and eliminating phosphorus waste in the environment is of 
great interest.  
 
1.3.1.3 Genetically Modified Phytase 
 
Phytases investigated in animal feeding trials are of microbial origin and are 
genetically modified to have enhanced thermostability and kinetic activity at 
pH 2.5 - 3.5 - the pH of the stomach (38). Optimal phytase activity in the 
stomach allows phytate to be degraded early in the intestinal tract. As a 
consequence, P and minerals cleaved from phytate pass through the entire 
gastrointestinal tract, contacting the intestinal epithelium more frequently, 
which increases opportunities for absorption.  
 
1.3.1.4 Supplementation 
 
Phytase research has primarily focused on determining its optimal use as a 
supplement in livestock feed. Animal feeding trials with phytase 
supplementation examine skeletal characteristics as evidence of phytase 
efficiency to increase phosphorus availability. Approximately 85% of 
phosphorus in the body is retained in the skeleton and skeletal characteristics 
and biomechanics are sensitive indicators of P status. Animals on a restricted 
P diet display symptoms of hypophosphatemia, such as rickets or 
osteomalacia (39,40). In swine, broiler chicks and rats, microbial phytase 
supplementation in the diet has been shown to improve bone properties, such 
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as breaking strength, percent ash analysis (a measure of bone mineralization), 
and bone geometry in animals fed a phosphorus or mineral deficient diet (41-
47). Phytase (Escherichia coli) supplementation at 1,000U/kg is able to replace 
approximately 0.20% inorganic phosphorus in the diet and rescue the bones of 
pigs receiving inadequate levels of inorganic phosphorus (48). In some 
situations, this would eliminate the need for the addition of iP in pig and 
poultry nutrition (48). Furthermore, in several feeding trials, improvements in 
bone characteristics and biomechanics were greater than those of the nutrient 
adequate control. (44-46,49,50). Phytase supplementation in swine fed a P-
adequate diet demonstrated an increase in bone mineral content in femur and 
metacarpal bones by 14-15% as well as a 9-11% increase in bone mineral 
density (29). These results suggest that in addition to an increase in P and 
mineral bioavailability, supplemental phytase may provide additional benefits 
to skeletal tissue, such as increase in bone strength and bone mass, in young 
animals. Therefore, dietary phytase supplementation showed potential to 
improve bone integrity and may be a strategy to reduce the risk of acquiring 
musculoskeletal disease that manifest in animals with compromised skeletons. 
  
1.3.2 Strontium 
 
Early research with stable strontium isotopes (Sr2+) focused on evaluating its 
toxicity in animals. These studies demonstrated a high tolerance in animals for 
strontium and symptoms of strontium toxicity, such as strontium rickets, 
where usually observed only when calcium was insufficient (51,52). For 
example, swine can tolerate strontium supplemented at 0.2 percent in diet 
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even though usual strontium consumption is approximately 0.007 percent for 
swine in a normal plant-based diet (51). These results rectified the initial 
confusion between stable strontium and radioactive strontium. Biological 
interest in strontium rose, especially when its ability to replace calcium in vivo 
was observed. Strontium and calcium are earth minerals and divalent cations 
(51,53). Their similar origin and chemistry may be allow them to share the 
same mechanism for absorption from the gastrointestinal tract and 
accumulating in bone (51). Strontium has a heterogeneous distribution in 
skeletal tissue. Bone turnover is greater in cancellous bone and thus cancellous 
bone accumulates more Sr compared to cortical bone (53).  
 
Strontium has a high affinity for bone and is incorporated into it by two 
mechanisms: surface exchange and ionic substitution (53). Surface exchange is 
the incorporation or absorption of Sr at the surface of the mature 
hydroxyapatite crystal. Alternatively, ionic substitution involves the 
replacement of calcium with strontium during the formation of the crystal 
(one strontium atom out of a 10 calcium can be substituted by strontium) (53). 
However, as the animal matures mechanisms develop which discriminate 
against strontium substitution for calcium (51). Studies with rats, monkeys, 
and humans have shown that strontium reaches a plateau in bone during oral 
administration with strontium ranelate or strontium chloride. In addition, 
once strontium treatment is stopped, it is rapidly eliminated form the bone 
suggesting that the mineral is only superficially incorporated into the bone 
(53).  
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1.3.2.1 Beneficial Effects on Bone 
 
Strontium supplementation not only makes strontium more available for its 
physical incorporation into skeletal tissue but also seems to impact bone 
remodeling cells in a manner that favors bone formation. Particularly, 
strontium ranelate has shown its ability to stimulate osteoblasts, but decrease 
osteoclasts differentiation and activity, thereby altering bone remolding to 
favor bone formation (26,54,55).  In non-human primates, strontium 
supplementation inhibited bone resorption as indicated by a decrease in 
osteoclast number, but not bone formation (56). In rats, strontium 
supplementation increased bone mass, as measured by an increase in 
trabecula number and thickness, as well as an increase in cortical density (26).  
The mechanism of strontium on bone cells is still unclear, but it is thought to 
act through calcium-sensing receptors (CsR) on bone cells to stimulate 
differentiation or apoptosis (57).  Overall, strontium supplementation 
increases strontium atoms on the bone surface matrix and stimulates bone 
cells to favor bone formation (55). These interactions lead to positive changes 
in microarchitecture and function in skeletal tissue, such as increased bone 
mass and breaking strength.  
 
We investigated dietary strontium supplementation in combination with 
phytase because previous studies showed an increase in strontium 
concentrations in the femur and metatarsal of young pigs fed supplemental 
phytase (29). Therefore, we were interested in if the increase in strontium 
concentration in bones by phytase was responsible for improvements in bone 
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paramaters and if additional strontium in the presence of phytase can further 
increase strontium accumulation in bones, and thus increase bone strength.  
 
1.3.3 Inulin 
 
Inulin, a linear fructan with a terminal alpha-D-glucose (β2-1 linkage), is 
present in plants, such as wheat and chicory root (28). Inulin is not digestible 
by human gastrointestinal enzymes and is instead fermented by bacteria in the 
colon (58). Studies with dietary inulin supplementation have shown the 
supplement to possess prebiotic properties as it increases beneficial bacteria 
populations, such as Lactobacillus and Bifidobacterium, in the gastrointestinal 
tract in animals (59). In addition, supplemental inulin has been shown to 
increase mineral absorption in the gastrointestinal tract (58). Colonic 
fermentation of inulin yields short chain fatty acids, such as acetate and 
butyrate, which lowers the pH of the large intestinal lumen. The decrease in 
pH seems to increase solubility of minerals, such as calcium, magnesium and 
zinc, which allows for their passive absorption by gut mucosal cells as well as 
diffusion paracellularly (60). The enhanced mineral absorption due to dietary 
inulun may also be due to changes in cecum morphology. By-products from 
bacterial fermentation of inulin, particularly butyrate, have been noted to alter 
cecum morphology, particularly an increase in mass and villus height (28). 
These changes in the intestinal epithelium most likely increase absorptive 
surfaces and thus enhance mineral absorption. Furthermore, increases in 
calcium binding proteins have been observed with dietary inulin 
supplementation and may better facilitate active calcium transport (61).  
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Inulin supplementation seems to improve iron bioavailability in a dose 
dependent manner when added to a corn and soybean meal diet fed to young 
pigs (62).  The mechanism responsible for the increase in iron with inulin is 
unclear. It was hypothesized that inulin might reduce or remove iron 
chelators, such as phytate, in the diet but a reduction in phytase activity was 
not observed. Dietary inulin might trigger an up regulation of genes encoding 
for Fe transporters in the enterocyte (59).  
 
1.3.3.1 Beneficial Effects on Bone  
 
Supplemental inulin increases mineral bioavailability and absorption due to 
its prebiotic properties in the gastrointestinal tract (61). Alterations in gut 
microbial populations leads to changes in lumen pH, cecum morphology and 
mineral transport proteins, which ultimately allow an organism to absorb and 
utilize minerals previously unavailable (28,58,60,61). In addition to the 
increase in mineral absorption, feeding trials with supplemental inulin in 
humans and animals have also shown beneficial effects on skeletal tissue 
(28,58,63). In rats fed inulin-type fructans, bone mineralization was improved 
as well as tibia breaking strength at the mid-diaphysis (28).  Furthermore, 
dietary inulin increased whole BMC and BMD and Ca absorption in human 
adolescents (63,64). These studies are particularly supportive of dietary 
inulin’s potential to increase bone integrity. Therefore, we investigated inulin 
supplementation with phytase to determine if the addition of inulin could 
further improve bone strength and mass beyond that of phytase 
supplementation alone.  
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1.4  Research Objectives 
 
Our objective was to investigate whether phytase supplementation in a high 
phosphorus diet can increase bone strength and mass in young pigs and mice. 
We hypothesize that the non-phosphorus by-products, minerals and inositol 
derivatives, from the enzymatic reaction of phytase with phytate are 
responsible for possible improvements in bone parameters examined in young 
animals. Furthermore, we examined two other known bone-impacting 
supplements, strontium and inulin, to determine if either had synergistic 
activity on bone properties when supplemented in the diet with phytase. In 
mice, we examined if phytase could improve bone properties when phytate, 
the intrinsic substrate of phytase, was absent from the diet. This experiment 
was designed to demonstrate if the phytase enzyme alone is able to improve 
bone properties.  
 
Overall, these experiments will better elucidate whether these dietary 
supplements (phytase, strontium, and inulin) can positively impact skeletal 
tissue, particularly by increasing bone strength and mass, when supplemented 
in the diet of young animals. The mouse experiment will also provide insight 
into the mechanism of phytase in improving bone characteristics. These 
studies will lay groundwork for future nutritional experiments that explore 
strategies to optimize bone health early in life as a means to reduce the risk of 
musculoskeletal diseases.
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CHAPTER TWO 
THE IMPACT OF DIETARY PHYTASE AND INULIN 
SUPPLEMENTATION ON BONE BIOMECHANICS IN YOUNG PIGS 
 
2.1 Abstract 
 
Increasing bone strength and mass early in life may result in a skeleton that is 
less susceptible to diseases. We investigated improving bone health via 
nutritional means and examined two dietary supplements; phytase and inulin. 
Previous studies have demonstrated potential benefits of phytase and inulin 
supplementation on skeletal tissue in humans, rats, and pigs. We conducted 
an experiment to compare the effects of microbial phytase (3,500U/kg, 
OptiPhos, JBS United, Sheridan, IN) and inulin (4%, Synergy Orafti, Tienen 
Belgium) supplemented alone or together on bone characteristics in young 
pigs. Thirty-five pigs (body weight: 8.5 ± 1.6 kg) were fed a corn-soybean-meal 
basal diet with 0.35% inorganic phosphorus (BD), BD + phytase, BD + inulin, 
or BD + phytase + inulin. At the end of 6 weeks, five pigs were selected from 
each diet group and one femur was analyzed from each animal using the 
three-point bending test. Supplemental phytase increased bending rigidity (p 
< 0.05), the moment of inertia medial-lateral, Iml (p = 0.08), and the moment of 
inertia anterior-posterior, Iap (p = 0.06). Inulin supplementation altered (p < 
0.05) the ellipticity index of femurs and enhanced (p = 0.06) femoral height. 
Femoral mineral analysis showed that phytase supplementation increased Mg 
(p < 0.05), Sr (p < 0.001), and Zn (p < 0.001) concentrations and inulin 
supplementation increased (p < 0.05) Ca, K, Mg, Na, P, and Sr concentrations 
in cortical bone. In cancellous bone, phytase supplementation enhanced (p < 
0.05) S, Sr, and Zn concentration and inulin supplementation increased (p < 
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0.05) Cr concentration. Based on our analysis, phytase supplementation 
impacted bending rigidity and both supplements had an effect on femoral 
mineral composition when supplemented in the diet alone. It may be 
important to extend the length of this study beyond 6 weeks to better 
determine if these supplements can influence bone properties in older 
animals.  
 
2.2 Introduction 
 
In this study, we examined bone strength in young pigs fed supplemental 
phytase, and acid phosphatase, and inulin, a carbohydrate. These 
supplements have shown potential for improving bone health in a variety of 
species (28,29,48,58). We conducted this feeding trial to better understand the 
extent and nature of these skeletal improvements over a course of 6 weeks. A 
high phosphorus (P) diet was used to eliminate any possible beneficial effects 
on skeletal tissue from the increase in phosphorus from the degradation 
phytate by phytase. Therefore, improvements in bone parameters examined 
would most likely be due to phytase or the non-phosphorus by-products 
(minerals and inositol phosphates) of the enzymatic reaction. In addition to 
breaking strength, bone geometry and material properties were examined to 
better understand how phytase and inulin might be influencing bone 
biomechanics.  Overall, this study of supplemental phytase and inulin will 
better guide the use of these dietary supplements and define their role for 
combating musculoskeletal disease.  
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2.3  Methods 
 
2.3.1  Experimental diet 
 
The four experimental diets were composed from a corn-soybean-meal basal 
diet (BD) containing 0.35% inorganic phosphorus (P) concentration. The 
microbial phytase used was Escherichia coli AppA2 (OptiPhos, JBS United, 
Sheridan, IN) at 3500 U/kg After the phytase activity was analyzed, the 
phytase enzyme was added to the diets at feed mixing (65). Phytase activity in 
the experimental diets was further verified by laboratory analysis. Inulin 
(Synergy, Orafti, Tienen Belgium) was supplemented at 4% of the diet. 
 
2.3.2  Experimental animals and design  
 
Thirty-five mixed gender weanling pigs (Yorkshire x Hampshire x Laundrace, 
8.5 ± 1.0 kg of body weight) from the Cornell University Swine Farm were 
weaned at 4 weeks of age and assigned to one of four dietary treatment 
groups based on body weight, litter and sex. This study was designed as a 2 x 
2 factorial arrangement of diet treatments (2 levels of phytase, 0 and 3500 
U/kg) and 2 levels of inulin (0 and 4%) in a high phosphorus diet (0.35% 
inorganic phosphorus, iP) and was conducted for 6 weeks. The treatments 
groups were BD, BD + phytase, BD + inulin, and BD + phytase + inulin. Pigs 
were penned in an environmentally controlled barn (20-25ºC; 12 h light: 12 h 
dark cycle) and were fed ad libitum. The experimental protocol was approved 
by the Institutional Animal Care and Use Committee of Cornell University. 
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2.3.3  Growth performance and sample collection 
 
The body weights of individual pigs were measured initially (wk 0) and then 
biweekly. Blood samples of individual pigs were collected initially and 
biweekly from the cranial vena cava into heparinized tubes after an overnight 
fast (8 h). The collected whole blood samples were chilled on ice and 
centrifuged at 3000 x g for 10 min at 4ºC (GS-6KR centrifuge, Beckman 
Instruments). Plasma samples were stored at -20ºC until inorganic phosphorus 
concentration (PIP) and alkaline phosphatase (AKP) activity assays were 
performed. At the end of the experiment, five pigs were selected from each 
group for biomechanical and bone composition analysis and were killed by 
electrical stunning and exsanguinations. The right rear limb of each animal 
was amputated and stored at -20°C until the femur could be isolated for the 3-
point mechanical bending test.  
 
2.3.4  Plasma biochemical assays 
 
Plasma samples were thawed and then deproteinated with 12.5% 
tricholoacetic acid. Plasma samples were assayed for inorganic P 
concentrations using Elon (p-methylaminophenol sulfate) solution (66). The 
hydrolysis of p-nitrophenol phosphate to p-nitrophenol was used to measure 
plasma alkaline phosphatase activity (67). The enzyme unit was defined as 
1µmol of p-nitrophenol released per minute at 30ºC.   
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2.3.5  Mineral composition analysis 
 
After biomechanical testing, cortical and cancellous samples were collected 
from the femur for mineral analysis. A bone saw was used to collect a cortical 
sample at the mid diaphysis. A stainless steel scalpel was used to further 
isolate the cortical bone from any remaining tissue. Cancellous bone was 
collected at the ephiphysis using a stainless trephine (Michele Trephine 6 1/4" 
shaft, 5/16" O.D., graduated 1/4 to 1 1/4") and chisel. Specimens were 
defatted in a chloroform-methanol solution (2:1) for three days with a change 
in solution every 24 h. The samples were air-dried for 24 h at room 
temperature and then for 24 h at 105ºC to obtain a dry weight. Ash weight was 
determined by ashing bone samples in a box furnace (Lindberg Moldatherm 
1100°C box furnace; model BF51748A) for 72 h at 600ºC. Femoral percent ash 
was calculated as 100 x (ash weight/dry weight). 
 
To detect ash mineral composition, ash samples (0.1 g) were digested in 1 ml 
of concentrated nitric and perchloric acid (1:1, v:v) and the mixture was heated 
at 220ºC until dry. The ash was dissolved in 20 ml of 5% nitric acid and 
mineral composition was determined using an inductively coupled argon 
plasma spectrophotometer (ICAP 61E Trace Analyzer, Thermo Jarell Ash 
Corporation). Standard reference materials (1573a, tomato leaves, and 1577b, 
bovine liver; National Institute of Standards and Technology) were used to 
validate the analytical procedures (68). The transfer optics had been modified 
using a short depth of field transfer optics to reduce matrix effects (Ruzke MA, 
2002; US Patent, 2002). The same procedure was used to analyze the mineral 
composition of diet and plasma. For diet, 0.5 g were dissolved in 30.25 ml of 
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5% nitric acid while 0.5 ml of plasma was dissolved in 10.25 ml of 5% nitric 
acid. Mineral concentration values were an average of three replicates. 
 
2.3.6  Femur geometry and whole bone strength 
 
The right femur was prepared for mechanical testing by removing all 
surrounding skin, muscle, and soft tissue. The femur was wrapped in gauze 
soaked in normal saline to maintain the normal physiological environment. 
Bones were weighed wet and length was measured. Femurs were allowed to 
thaw at room temperature prior to mechanical testing (model 4500; Instron 
Corp, Canton, MA).  All specimens were loaded in the anterior-posterior 
direction at a crosshead speed of 50 mm/min and the sample rate was 10 
points/s. Specimen supports were 50 mm apart. A load-deformation curve 
was recorded for each sample for data analysis. Post-failure femurs were cut 
with a bone saw at the load site to expose a cross section. The medial-lateral 
axis, anterior-posterior axis, and cortical thickness at the medial and lateral 
position were measured with digital calipers and used to calculate the 
moment of inertia. Mechanical properties of bones were calculated using the 
following formulas (Fig. 2.1): 
 
Moment (M) = PL/4 
Bending stiffness (EI) = mL3/48 
 
Moment of inertia approximated using the hollow ellipse formula:  
Iml = π/4 (boao3 - biai3) 
Iap = π/4 (aob03 - aibi3)
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Figure 2.1  Schematic illustration of cross section of bone through the diaphysis. Letters indicate where 
measurements were taken. Cortical thickness medial-lateral (ct. th.ml), cortical thickness anterior-posterior (ct. th.ap), 
outer radius medial-lateral (ao), inner radius medial-lateral (ai), outer radius anterior-posterior (bo), and inner radius 
medial-lateral (bi).  
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ct. th.ml 
ct. th.ap 
ai 
bo 
ao 
bi 
Anterior-posterior axis 
Medial-lateral axis 
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P = maximal load at failure 
L = span 
m = slope of the load-displacement curve 
Iml = moment of inertia of the medial-lateral axis 
Iap = moment of inertia of the anterior-posterior axis 
ao = outer radius of the medial-lateral axis 
ao = a/2 
a = width (diameter) of the medial-lateral axis 
ai = interior radius of the medial-lateral axis 
ai = (ao/2) - ct. th. 
ct. th. = cortical thickness (average of medial and lateral) 
bo = outer radius of the anterior-posterior axis 
bo = b/2 
b = height (diameter) of the anterior-posterior axis 
bi = interior radius of the anterior-posterior axis 
bi = (ao/bo)ai 
 
2.3.7  Statistical analysis 
 
Data were analyzed using SigmaPlot 9.0 (2004 SYSTAT Software Inc.). Main 
effects of dietary phytase and inulin supplementation were analyzed using 
two-way ANOVA as a 2 x 2 factorial arrangement of diet treatments with 
significance level set at p ≤ 0.05. Holm-Sidak method was used for post-hoc 
analysis with overall significance level equal to 0.05.  
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2.4  Results 
 
2.4.1  Growth performance and plasma biochemical assays 
 
Body weight, average daily gain, and gain: feed ratio were not affected by 
phytase or inulin supplementation (Table 2.1).  At 6 weeks, dietary phytase 
supplementation decreased (p = 0.05) plasma inorganic phosphorus 
concentration in pigs (Table 2.2).  There was no observed effect of treatments 
on plasma alkaline phosphatase activity.  
 
2.4.2  Plasma mineral analysis 
 
Phytase supplementation had a marginal effect (p = 0.09) on plasma Fe 
concentration and increased plasma Fe concentration approximately 58% in 
pigs fed BD + phytase compared to pigs fed BD at 5 weeks (Table 2.3 and 2.4). 
Inulin supplementation had a marginal increase (p = 0.05) on plasma S 
concentration. The BD + phytase + inulin diet had a significant impact (p < 
0.05) on Ca, Mg, S, and Sr and had a marginal impact Na (p = 0.06), P (p = 
0.08), and K (p = 0.05). For the most part, the individual supplements 
increased plasma mineral concentration; however the combined supplement 
diet returned plasma minerals concentration values to approximately those of 
the control, or BD.  
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Table 2.1 Growth performance of swine during the 6-week feeding trial1 
1 Values are means, n = 5 
2 Phy, phytase; Inu, inulin 
 
 Treatment    
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Inulin, % 0 0 4 4 SEM Phytase Inulin Phy x Inu2 
Body Weight, kg         
Wk 0 8.3 8.4 8.7 8.4 1.0 0.8 0.8 0.7 
Wk 5 30.9 31.1 30.2 29.6 2.2 0.9 0.3 0.8 
Average Daily Gain, kg          
Wk 0 0.3 0.3 0.3 0.3 0.2 0.2 0.6 0.6 
Wk 5 0.8 0.8 0.7 0.7 0.5 0.6 0.09 0.6 
Gain: Feed         
Wk 0 0.6 0.9 0.7 0.8 0.09 0.2 0.8 0.4 
Wk 5 0.5 0.5 0.5 0.5 0.07 0.9 0.9 0.8 
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Table 2.2 Plasma inorganic phosphorus (PIP) and alkaline phosphatase activity (AKP) of swine at wk 0 and wk 6 of  
the feeding trial1 
1 Values are means, n = 5 
2 Phy, phytase; Inu, inulin 
3 To convert mg/dl to mmol/L multiply by 0.323.
  Treatment      
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Inulin, % 0 0 4 4 SEM Phytase Inulin Phy x Inu3 
Plasma Inorganic Phosphorus, mg/dl3         
Wk 0  8.0 7.8 7.6 7.4 0.8 0.6 0.3 1.0 
Wk 5 11.6 9.01 10.4 9.7 1.3 0.05 0.8 0.3 
Alkaline Phosphatase Activity, U/ml         
Wk 0 90.1 86.3 110.8 95.9 22.2 0.4 0.2 0.6 
Wk 5 80.8 91.6 89.2 83.3 21.7 0.8 1.0 0.5 
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Table 2.3 Plasma macromineral concentration3 (mg/L) during the feeding trial 1  
1 Values are means, n = 5 
2 Phy, phytase; Inu, inulin 
3 To convert mg/L to mmol/L multiply values by the factor in parentheses next to each element, except for K. 
4 To convert mg/L to mmol/L (mEq/L) divide values by the factor in parentheses. 
 Treatment    
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Inulin, % 0 0 4 4 SEM Phytase Inulin Phy x Inu2 
Na (0.0435)         
Wk 0 1891.8 1877.8 1869.5 1818.7 14.4 0.3 0.2 0.5 
Wk 5 1742.6 1875.7 2024.9 1584.2 74.5 0.3 1.0 0.06 
S (0.0312)         
Wk 0 448.1 411.6 464.7 424.2 20.1 0.4 0.7 1.0 
Wk 5 453.2 532.6 508.1 285.4 30.4 0.1 0.05 0.004 
K (39.09)4         
Wk 0 295.9 280.4 308.5 274.8 29.7 0.1 0.8 0.6 
Wk 5 251.2 314.1 338.6 242.7 73.3 0.7 0.8 0.05 
P (0.0323)         
Wk 0 112.8 110.6 116.3 116.2 3.2 0.9 0.5 0.9 
Wk 5 122.2 132.9 145.8 105.3 7.1 0.3 0.9 0.08 
Ca (0.0249)         
Wk 0 93.8 93.7 92.1 89.7 1.3 0.7 0.3 0.7 
Wk 5 90.9 105.5 109.7 85.2 4.3 0.5 0.9 0.03 
Mg (0.0412)         
Wk 0 18.3 18.3 17.2 17.2 0.3 1.0 0.1 1.0 
Wk 5 15.0 17.7 18.1 14.6 0.7 0.8 1.0 0.04 
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Table 2.4 Plasma micromineral concentration3 (µg/L) in swine during the feeding trial1 
1 Values are means, n = 5 
2 Phy, phytase; Inu, inulin 
3 To convert µg/L to µmol/L multiply values by the factor in parentheses next to each element.
 Treatment    
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Inulin, % 0 0 4 4 SEM Phytase Inulin Phy x Inu2 
Fe (0.018)         
Wk 0 2326.5 1514.4 1217.2 1643.7 933.6 0.7 0.3 0.2 
Wk 5 1958.4 3015.6 2358.4 3467.8 1341.4 0.1 0.5 1.0 
Cu (0.016)         
Wk 0 1654.2 1679.3 1785.4 1841.6 187.7 0.7 0.1 0.9 
Wk 5 1487.7 1617.7 1869.0 1438.3 345.2 0.4 0.6 0.1 
Zn (0.015)         
Wk 0 533.7 518.9 511.4 483.0 14.9 0.5 0.4 0.8 
Wk 5 944.4 1169.9 1173.7 1040.5 60.8 0.7 0.7 0.2 
Sr (0.011)         
Wk 0 31.3 29.2 26.3 26.9 1.9 0.9 0.4 0.7 
Wk 5 30.8 42.2 44.5 38.2 2.1 0.5 0.2 0.04 
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2.4.3  Ash fraction and bone mineral analysis 
 
Dietary supplementation with phytase, inulin, or both did not produce any 
significant differences in cortical or cancellous ash fraction (Table 2.5).  
However, inulin supplementation increased (p = 0.08) percent ash in 
cancellous bone.  
 
In cortical bone, phytase supplementation increased (p < 0.05) Mg, and Sr and 
Zn concentrations (p < 0.001) (Table 2.6). Inulin supplementation increased (p 
< 0.05) Ca, K, Mg, Na, P, and Sr concentrations. No differences in minerals 
analyzed were observed in animals fed BD + phytase + inulin in cortical bone. 
In cancellous bone, phytase supplementation enhanced (p < 0.05) S and Sr 
concentrations and greatly increased  (p < 0.001) Zn concentration (Table 2.7). 
 
Inulin supplementation increased (p < 0.05) Cr concentration in cancellous 
bone. Femurs from pigs fed BD + phytase + inulin had an increase (p < 0.05) in 
Mg and Cr concentrations as well as an increase (p = 0.06) in P concentration 
in cancellous bone.  
  
2.4.4  Femur geometry and whole bone strength 
 
Dietary phytase supplementation increased (p < 0.05) bending rigidity in 
swine femora (Table 2.8). Additionally, supplemental phytase marginally 
increased the medial-lateral moment of inertia, Iml, (p = 0.08) and anterior-
posterior moment of inertia, Iap (p = 0.06). Inulin supplementation altered (p < 
0.05) ellipticity index of femurs and marginally enhanced (p = 0.06) femoral 
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Table 2.5  Femur percent ash at two skeletal sites1 
1 Values are means, n = 5 
2 Phy, phytase; Inu, inulin 
 
 Treatment    
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Inulin, % 0 0 4 4 SEM Phytase Inulin Phy x Inu2 
Cortical 72.6 72.3 72.9 72.2 1.7 0.6 0.1 0.8 
Cancellous 50.5 49.2 51.0 52.2 1.9 1.0 0.08 0.2 
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Table 2.6  Mineral concentration of cortical femur of pigs at wk 61 
1 Values are means, n = 5 
2 Phy, phytase; Inu, inulin 
3 To convert mg/kg to mmol/kg see footnote 3 in Table 2.3 
4 To convert mg/kg to mmol/kg see footnote 4 in Table 2.3 
5 To convert µg/kg to µmol/kg see footnote 3 in Table 2.4 
6 To convert µg/kg to µmol/kg multiply by 0.019 
 Treatment    
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Inulin, % 0 0 4 4 SEM Phytase Inulin Phy x Inu2 
Macrominerals3, mg/kg         
K4 2902 2820 2911 2701 242.0 0.2 0.7 0.6 
S 911.1 980.5 962.4 971.0 48.3 0.1 0.4 0.2 
Ca 391.0 394.3 399.8 399.8 4.4 0.5 0.005 0.5 
P 192.0 192.6 195.2 195.6 1.8 0.6 0.003 0.9 
Na 8.7 8.9 9.0 9.1 0.2 0.1 0.008 0.3 
Mg 7.3 7.7 7.7 7.8 0.2 0.04 0.02 0.3 
Microminerals5, µg/kg         
Zn 224.7 272.8 242.7 289.3 20.8 <0.001 0.1 1.0 
Sr 91.7 108.4 101.8 114.8 7.0 <0.001 0.03 0.6 
Fe 25.9 49.6 43.9 55.5 58.1 0.6 0.7 0.8 
Cr6 11.7 11.9 11.8 11.6 0.4 0.9 0.6 0.4 
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Table 2.7  Mineral concentration in cancellous femur at wk 61 
1 Values are means, n = 5 
2 Phy, phytase; Inu, inulin 
3 To convert mg/kg to mmol/kg see footnote 3 in Table 2.3 
4 To convert mg/kg to mmol/kg see footnote 4 in Table 2.3 
5 To convert µg/kg to µmol/kg see footnote 3 in Table 2.4 
6 To convert µg/kg to µmol/kg multiply by 0.019 
 
 Treatment    
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Inulin, % 0 0 4 4 SEM Phytase Inulin Phy x Inu2 
Macromineral3, mg/kg         
K4 4119.1 3375.0 4624.5 5143.8 830.5 0.8 0.02 0.1 
Ca 399.3 387.8 400.4 400.4 7.7 0.2 0.1 0.2 
P 202.4 197.4 200.4 202.3 3.4 0.4 0.4 0.06 
Na 13.2 12.8 13.5 12.1 1.0 0.09 0.7 0.3 
Mg 8.0 7.8 8.0 8.2 0.2 0.8 0.1 0.03 
S 3.0 2.7 3.3 2.8 0.3 0.03 0.2 0.4 
Microminerals5, µg/kg         
Fe 354.0 368.3 391.7 377.6 62.9 1.0 0.5 0.7 
Zn 299.0 371.5 302.6 382.6 23.9 <0.001 0.5 0.8 
Sr 98.3 108.4 98.5 115.3 7.5 0.002 0.3 0.4 
Cr6 11.8 10.9 11.9 12.5 0.6 0.6 0.02 0.04 
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Table 2.8 Geometric and biomechanical properties of swine femur after 6 weeks of dietary supplementations1 
1 Values are means, n = 5 
2 Phy, phytase; Inu, inulin 
 Treatment    
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Inulin, % 0 0 4 4 SEM Phytase Inulin Phy x Inu2 
Geometry         
Weight, g 134.6 135.7 132.9 133.9 8.7 0.8 0.7 1.0 
Length, mm 129.8 130.6 127.7 128.2 3.3 0.7 0.2 0.9 
Height (b), mm 18.2 19.4 19.6 19.9 0.9 0.1 0.06 0.3 
Width (a), mm 18.3 18.8 18.3 18.5 0.7 0.3 0.7 0.7 
Cortical thickness, mm 3.2 3.4 3.4 3.7 0.6 0.4 0.6 0.9 
         
Moment of Inertia, mm4         
Moment of inertia (Iap) 4343 5529 5482 5993 831.9 0.06 0.07 0.4 
Moment of inertia (Iml) 4348 5141 4790 5204 643.4 0.08 0.4 0.5 
Ellipticity index, (Iap/ Iml) 1.0 1.07 1.15 1.15 0.09 0.3 0.01 0.4 
         
Whole Bone Mechanics         
Maximum displacement, mm 4.1 4.7 5.1 4.1 0.9 0.7 0.6 0.08 
Breaking energy, J 4.0 6.0 7.1 5.9 2.8 0.7 0.3 0.3 
Bending Moment, N-m 30.1 33.8 29.6 32.3 5.4 0.3 0.7 0.9 
Bending Rigidity, N-m2 3.3 3.7 3.2 3.7 0.4 0.03 0.9 0.9 
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height (Figure 2.2). Femurs from swine fed BD + phytase + inulin displayed a 
marginal main effect (p = 0.08) with maximum displacement, resembling the 
value of the BD group.  
 
2.5  Discussion 
 
Phytase supplementation increased (p < 0.05) bending rigidity and bending 
moment by approximately 10%. Furthermore, phytase supplementation 
significantly altered the mineral composition of both cortical and cancellous 
bone. Most noticeably there were increases in Sr and Zn. The increase in Sr 
concentration in femur was approximately 15% in cortical bone and 10% in 
cancellous bone with phytase supplementation. Femur Zn concentration 
increased approximately 17% in cortical bone and 19% in cancellous bone with 
phytase supplementation compared to the BD treatment. Phytase 
supplementation had marginal effects on moment of interia, a measure of the 
distribution of the material of a beam around a cross section and an indicator 
of bone geometry, in the two axes measured, Iap and Iml. These geometrical 
changes and mineral composition may be responsible for the observed 
significant increase in bending rigidity. 
 
Similar alterations in bone mineral composition with phytase supplementation 
have been observed (29). The change in mineral composition in the skeletal 
tissue may be due to presence of more minerals. Phytate degradation by 
phytase releases P, mineral cations, and inositol intermediates from phytate. 
This enzymatic reaction increases the bioavailability of some minerals, such as 
Sr and Zn. The organism might be able to utilize minerals that were currently
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Figure 2.2  Mean anterior-posterior moment of inertia plotted against medial-lateral moment of inertia for each 
dietary treatment group to represent ellipticity index. The two reference lines represent an ellipticity index of 1 and 2 
and a schematic representation of the cross-section of bone accompanies each.  
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unavailable and these minerals may have an affinity for skeletal tissue. 
Interestingly, an increase in P concentration in plasma or bone was not 
observed with phytase supplementation, suggesting that the P status of the 
pigs was not altered and the increase in P availability from the degradation of 
phytate did not influence bone biomechanics (29,47). Therefore, the enzymatic 
activity of phytase may increase the bioavailability of non-phosphorus bone 
relevant minerals in healthy growing pigs and allow for incorporation of these 
minerals into skeletal tissue, positively impacting biomechanical parameters. 
Additionally, inositol derivatives released from the degradation of phytate 
may have also influenced bone strength, or bending rigidity. Phytase cleaves 
orthophosphate groups from phytase, yielding a spread of inositol 
derivatives. Inositol derivatives are important cellular signaling molecules and 
their increased abundance from supplemental phytase activity may benefit 
skeletal tissue. The inositol-1-4-5 pathway is important for intracellular 
calcium release, a prerequisite for the expression of bone matrix proteins, such 
as collagen and fibronectin (69,70). The presence of inostiol derivates may 
further activate such an inositol pathway, improving the material composition 
of bone.  
 
Inulin supplementation did not have any significant effect on the 
biomechanical parameters tested in the femur despite the significant impact (p 
= 0.01) on the ellipticity index. A 15% increase in ellipticity index was 
observed along the anterior-posterior axis and corresponds to the marginal 
increase (p = 0.07) in Iap. Furthermore, in cortical bone inulin supplementation 
significantly increased Ca, Mg, Na, and Sr and there was a non-significant 
increase of approximately 20% in Fe concentration. These changes in bone 
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mineral content were not accompanied by changes in plasma mineral 
concentration. 
 
All femurs were loaded in the anterior-posterior direction so it is interesting 
that the change in geometry with inulin supplementation did not result in a 
significant functional change.  Other studies have demonstrated significant 
biomechanical changes using three-point bending in rats with 10% inulin 
supplementation (28). In this study, inulin was supplemented at a lower level, 
4%, and perhaps three-point bending was able to detect functional changes in 
the femur due to geometric and material transformations of low-level inulin 
supplementation in swine.  
 
Inulin supplementation studies have shown this supplement to be effective in 
increasing Fe, Ca and Mg bioavailability through increased absorption in the 
large intestine in animals and humans (58,59). The changes in femur mineral 
content observed in this study may be due to the increased mineral absorption 
with inulin supplementation. It has been suggested that this increase in 
mineral absorption, and thus bioavailability, allows these minerals to be 
incorporated into skeletal tissue (58). Furthermore, the geometric changes in 
femur may be due to this change in mineral composition. Distribution of these 
minerals made available by inulin, might favor incorporation along the 
anterior-posterior axis of skeletal tissue. However, percent ash analysis of 
cortical and cancellous bone suggests that mineral content did not increase, 
but only mineral composition. Perhaps, percent ash analysis at only a cortical 
and cancellous site bone is not representative of whole bone ash or mineral 
content. Performing DXA analysis on these femurs might resolve the issue of 
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whether the changes in mineral makeup is due to an increase in 
mineralization, of these minerals in bone.  
 
The combined phytase and inulin, BD + phytase + inulin, treatment did not 
have any effect on bone biomechanics or geometry examined; nonetheless this 
treatment group did have some significant effects on non-phosphorus plasma 
parameters and cancellous mineral profile. The lack of interaction between 
phytase and inulin on bone biomechanics indicates that these two 
supplements probably are most effective on skeletal parameters when 
supplemented independently and no synergism is apparent.   
 
It is unclear how increases and decreases of individual minerals in plasma and 
bone influence bone biomechanics. All minerals examined are shown in the 
tables, but it is unknown how each mineral specifically influences the material 
and functional properties of bone. Plasma mineral analysis was performed 
primarily to examine P and Ca status, and ensure that these were within 
normal physiological range. Bone mineral analysis was performed to 
collectively examine any change in mineral composition and better 
understand the mechanism of phytase and inulin. 
 
In conclusion, the individual supplements, phytase and inulin, had an impact 
on the bone characteristics examined and both may benefit skeletal tissue 
through their ability to increase the bioavailability of bone-relevant minerals. 
Phytase supplementation had a significant impact on bending rigidity and 
femur mineral composition. Positive changes in bending moment or rigidity 
were not observed in the inulin treatment group despite both geometric and 
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mineral transformations in the femur. Further examination of phytase and 
inulin supplementation is necessary to determine their use in the prevention 
of musculoskeletal diseases. Additional supplementations studies should 
include DXA analysis to better interpret the observed changes is femur 
mineral composition. Evaluating the effects of these supplements for greater 
than 6 weeks is also important to determine if the positive effects observed in 
skeletal tissue are sustainable as the animal matures. 
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CHAPTER THREE 
THE IMPACT OF DIETARY PHYTASE AND STRONTIUM 
SUPPLEMENTATION ON BONE BIOMECHANICS OF YOUNG PIGS 
 
3.1 Abstract 
 
Maximizing bone strength and mass early in life may provide protection 
against some musculoskeletal diseases, such as osteochondrosis and 
osteoporosis. The aim of this study was to examine if two dietary 
supplements, phytase and strontium, can enhance bone strength and mass 
when added to the diet of young animals. Fifty-two mixed gender weanling 
pigs (Yorkshire x Hampshire x Laundrace, 10.9 ± 0.95 kg of body weight) were 
fed a corn-soybean-meal basal diet with 0.35% inorganic phosphorus (BD), BD 
+ phytase (3500U/kg, OptiPhos, JBS United, Sheridan, IN), BD + strontium (50 
mg/kg strontium as SrCO3, Alfa Aesar, Ward Hill, MA), or BD + phytase + 
strontium for 10 weeks. Femurs were collected for mechanical testing at 5 
weeks (n = 13). Both supplements had marginal effects on bone biomechanics 
in young pigs. Phytase supplementation increased (p = 0.09) bending rigidity 
and strontium supplementation had a marginal effect (p = 0.09) on energy to 
break. Dual x-ray energy absorptiometry (DXA) analysis of femurs at 5 and 10 
weeks showed that phytase supplementation increased (p < 0.05) bone 
mineral content in the femur at 5 weeks and strontium supplementation 
increased bone mineral density (BMD) at 10 weeks. In conclusion, 
independent supplementation with phytase and strontium appeared to 
positively impact skeletal tissue in a high phosphorus diet in young pigs.  
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3.2 Introduction 
 
The results from the study described in Chapter 2 motivated us to conduct a 
follow-up study exploring the impact of dietary phytase supplementation on 
the skeleton of young pigs beyond 6 weeks. In this study, phytase 
supplementation was extended to 10-weeks. A total of 52 pigs were used in 
this study, allowing us to examine a subset of animals at 5-weeks for 
comparison. In addition, because we observed an increase in strontium 
content in swine femur in the previous study, we included supplemental 
strontium in this feeding trial to determine if an increase in strontium 
bioavailability can further improve bone strength, particularly when 
combined in the diet with phytase. Overall, the purpose of this study was to 
examine if there is an additive effect on bone strength in young pigs fed 
supplemental strontium and phytase together.  
 
3.3  Methods 
 
3.3.1  Experimental diet 
 
The four experimental diets were composed of a corn-soybean-meal basal diet 
(BD) containing 0.35% inorganic phosphorus (P) concentration. The microbial 
phytase used was Escherichia coli AppA2 (OptiPhos, JBS United, Sheridan, IN), 
at 3500 U/kg. After the phytase activity was analyzed, the phytase enzyme 
was added to the diets at feed mixing (65). Phytase activity in the 
experimental diets was further verified by laboratory analysis. Strontium 
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(SrCO3, Alfa Aesar, Ward Hill, MA) was supplemented in the diet at 50 
mg/kg. 
 
3.3.2 Experimental animals and study design 
 
Fifty-two mixed gender weanling pigs (Yorkshire x Hampshire x Laundrace, 
10.9 ± 0.95 kg of body weight) from the Cornell University Swine Farm were 
weaned at 4 weeks of age and assigned to one of four dietary treatment 
groups based body weight, litter and sex. This study was designed as a 2 x 2 
factorial arrangement of diet treatments (2 levels of phytase, 0 and 3500 U/kg) 
and 2 levels of strontium (0 and 50 mg/kg) in a high phosphorus diet (0.35% 
inorganic phosphorus, an amount that exceeds the NRC requirement for 
inorganic phosphorus) (71,72). As in the previous study, swine were fed a 
high phosphorus diet to eliminate any phosphorus influence on skeletal tissue 
from the degradation of phytate (73). The treatments groups were BD, BD + 
phytase, BD + strontium, and BD + phytase + strontium. The experiment was 
conducted for 10 weeks. At 5 weeks, five pigs were selected for skeletal tissue 
collection. At 10 weeks, the remaining pigs (n = 8) were sacrificed for skeletal 
tissue collection. Pigs were penned in an environmentally controlled barn (20-
25ºC; 12 h light: 12 h dark cycle) and fed ad libitum. The experimental protocol 
was approved by the Institutional Animal Care and Use Committee of Cornell 
University. 
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3.3.3  Growth performance and sample collection 
3.3.4  Plasma biochemical assays 
3.3.5  Mineral composition analysis 
3.3.6  Femur geometry and whole bone strength 
3.3.7  Statistical analysis 
 
Refer to Chapter 2. 
 
3.3.8 Dual energy x-ray absorptiometry (DXA) 
 
Bone mineral content (BMC) and bone mineral density (BMD) were measured 
a Hologic densitometry system (Discovery A, S/N 82243) at the Human 
Metabolic Research Unit (HMRU) of Cornell University. Femurs were scanned 
in the anterior-posterior position and supported by plexiglass to maintain this 
orientation during scanning. The lumbar spine program was used for analysis 
(version 12.4.2:3). 
 
3.4  Results 
 
3.4.1  Growth performance  
 
During the 10-week feeding trial, there were no significant differences in body 
weight or gain: feed ratio due to phytase and/or strontium supplementation 
(Table 3.1). The pigs feed BD + phytase + strontium had an increase in body 
weight at week five (p = 0.07) and week 10 (p = 0.09). At 5 weeks, BD + 
phytase + strontium significantly (p < 0.05) increased average daily gain, but 
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Table 3.1 Growth performance of swine during the 10 week feeding trial1 
1 Values are means. Wk 0, n = 13 per treatment group; Wk 5, n = 13 per treatment group; Wk 10, n = 8 for BD and BD 
+ phytase + strontium; n = 7 for BD + phytase and BD + strontium 
2 Phy, phytase; Sr, strontium 
 
 
 Treatment    
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Strontium, mg/kg 0 0 50 50 SEM Phytase Strontium Phy x Sr2 
Body Weight, kg         
Wk 0 10.9 10.8 10.9 11.1 0.1 0.8 0.6 0.5 
Wk 5   32.8 31.2 31.1 32.5 0.4 0.9 0.7 0.04 
Wk 10  65.3 61.8 63.9 65.5 0.7 0.5 0.4 0.09 
Average Daily Gain, kg         
Wk 0 0.4 0.4 0.4 0.5 0.01 0.7 0.3 0.4 
Wk 5   0.9 0.8 0.8 0.8 0.01 0.5 0.1 0.02 
Wk 10  0.9 0.9 0.9 0.9 0.03 0.7 0.9 0.7 
Gain: Feed         
Wk 0 0.6 0.6 0.6 0.6 0.01 0.9 0.9 0.6 
Wk 5   0.6 0.6 0.6 0.6 0.01 0.3 0.1 0.9 
Wk 10  0.3 0.4 0.4 0.4 0.01 0.3 0.1 0.3 
  56 
this effect was not observed at 10 weeks.  
 
3.4.2  Plasma biochemical assays and mineral analysis 
 
Phytase supplementation increased (p = 0.08) plasma AKP at week 10 (Table 
3.2). The combination supplementation treatment did not alter AKP values.  
Phytase supplementation had a marginal effect (p = 0.08) on plasma inorganic 
phosphorus concentration (PIP) at week 5. Neither BD + strontium nor BD + 
phytase + strontium treatment had an apparent effect on PIP at week 5 or 10. 
 
Phytase supplementation increased (p < 0.05) plasma Ca and Zn concentration 
at week 10 and decreased (p = 0.08) plasma P concentration at week 5 (Table 
3.3 and 3.4). Strontium supplementation had an increase (p < 0.001) in plasma 
Sr concentration at week 5 and 10. Pigs fed BD + phytase + strontium had an 
increase (p < 0.05) in plasma Zn concentrations at 5 and 10 weeks.  
 
3.4.3  Dual energy x-ray absorptiometry (DXA) 
 
Phytase supplementation resulted in approximately a 5 percent increase (p < 
0.05) in femur BMC at week 5 compared to the BD treatment (Figure 3.1). No 
effects were observed in femur from pigs fed BD + phytase or the BD + 
phytase + strontium supplement with DXA analysis. At week 10, strontium 
supplementation increased (p < 0.05) femur mineral density (Figure 3.2). DXA 
analysis showed no effect of BD + phytase or BD + phytase + strontium at 
week 10.  
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Table 3.2 The change in plasma inorganic phosphorus (PIP) and alkaline phosphatase (AKP) activity in swine during 
the 10 wk feeding trial1 
1 Values are means. Wk 5, n = 13 and Wk 10, n = 8 for BD and BD + phytase + strontium; n =7 for BD + phytase and BD 
+ strontium  
2 Phy, phytase; Sr, strontium  
3 Statistical analyses were performed on the change from baseline, wk 0. 
4 To convert mg/dl to mmol/L multiply by 0.323. 
  Treatment      
Phytase, U/kg 0 3500 0 3500  Main effect, p-value3 
Strontium, mg/kg 0 0 50 50 SEM Phytase Strontium Phy x Sr2 
Plasma Inorganic Phosphorus4, mg/dL         
Δ Wk 5 10.9 10.4 11.3 10.4 0.09 0.08 0.4 0.6 
Δ Wk 10  9.4 9.9 10.1 10.4 0.57 0.3 0.7 0.8 
Alkaline Phosphatase Activity, U/ml         
Δ Wk 5 121.5 133.7 111.8 131.3 0.06 0.4 1.0 0.1 
Δ Wk 10 78.97 89.7 89.9 96.6 0.14 0.08 0.2 0.2 
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Table 3.3 Plasma macromineral concentration3 (mg/L) during the 10 week feeding trial1 
1 Values are means. Wk 0, n = 13 per treatment group; wk 5, n = 13 per treatment group; wk 10, n = 8 for BD and 
BD + phytase + strontium; n = 7 for BD + phytase and BD + strontium. 
2 Phy, phytase; Sr, strontium 
3 To convert mg/L to mmol/L multiply values by the factor in parentheses next to each element, except for K. 
4 To convert mg/L to mmol/L (mEq/L) divide values by the factor in parentheses.
 Treatment    
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Strontium, 
mg/kg 
0 0 50 50 SEM Phytase Strontium Phy x Sr2 
Na (0.0435)         
Wk 0 1911 1893 1887 1883 42.1 0.6 0.4 0.7 
Wk 5 2713 2705 2690 2665 57.6 0.6 0.3 0.8 
Wk 10 3469 3489 3375 3570 148 0.1 0.9 0.2 
S (0.0312)         
Wk 0 356.7 362.1 303.2 351.2 34.0 0.1 0.06 0.2 
Wk 5 679.9 651.6 669.7 671.4 26.5 0.3 0.7 0.3 
Wk 10 537.7 525.7 542.7 542.4 42.0 0.8 0.6 0.9 
P (0.0323)         
Wk 0 110.7 107.8 103.31 109.5 7.4 0.7 0.4 0.2 
Wk 5 130.9 128.7 134.7 128.8 4.5 0.08 0.4 0.4 
Wk 10 128.7 125.7 125.9 129.3 8.4 1.0 0.9 0.4 
Ca (0.0249)         
Wk 0 101.3 100.9 96.5 100.0 2.9 0.3 0.05 0.2 
Wk 5 112.2 110.4 109.4 110.1 2.7 0.7 0.3 0.4 
Wk 10 107.5 111.6 105.9 112.6 4.5 0.02 0.9 0.5 
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Table 3.4 Plasma micromineral concentration3 (µg/L) during the 10 week feeding trial 
1 Values are means. Wk 0, n = 13 per treatment group; wk 5, n = 13 per treatment group; wk 10, n = 8 for BD and 
BD + phytase + strontium; n = 7 for BD + phytase and BD + strontium. 
2 Phy, phytase; Sr, strontium 
3 To convert µg/L to µmol/L multiply values by the factor in parentheses next to each element. 
 
 
 Treatment    
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Strontium, mg/kg 0 0 50 50 SEM Phytase Strontium Phy x Sr2 
Fe (0.0179)         
Wk 0 1601 1542 1495 1600 100 0.6 0.6 0.8 
Wk 5 3621 2625 2857 2893 90.0 0.3 0.6 0.3 
Wk 10 3295 4286 4000 2953 190 1.0 0.7 0.2 
Zn (0.0153)         
Wk 0 809 821 764 861 64.6 0.1 0.9 0.2 
Wk 5 1261 1235 1165 1404 109 0.6 0.5 0.02 
Wk 10 1062 1088 982 1238 107 0.02 0.5 0.04 
Sr (0.0114)         
Wk 0 30.2 28.4 28.4 31.6 2.7 0.6 0.6 0.07 
Wk 5 45.6 42.3 192 194 9.1 0.9 <0.001 0.6 
Wk 10  40.3 44.5 180 190 12.0 0.3 <0.001 0.7 
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A B 
Figure 3.1  Dual X-ray absorptiometry analysis of femurs at 5 weeks during the supplemental feeding trial. 
The mineral content (A) and mineral density (B) were obtained with DXA analysis. Bars represent mean values 
per treatment group and error bars are the standard error.  The asterisks (A) represent the significant main 
effect (p < 0.05) observed with phytase supplementation on femur mineral content. For all treatment groups n 
= 8. Phy, phytase; Sr, strontium; BD, basal diet. 
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. * * B. 
Figure 3.2  Dual X-ray absorptiometry analysis of femurs after 10 weeks of the feeding trial. The femur mineral 
content (A) and mineral density (B) were obtained with DXA analysis. Bars represent mean values per treatment 
group and error bars are the standard error. The asterisks (B) represent the significant main effect (p < 0.05) 
observed with strontium supplementation on bone mineral density. For all treatment groups BD and BD + 
phytase + strontium, n = 8.  For treatment groups BD + phytase and BD + strontium, n = 7. Phy, phytase; Sr, 
strontium; BD, basal diet. 
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3.4.4  Femur geometry and whole bone strength 
 
Weight, length, height (anterior-posterior axis), width (medial-lateral axis), 
and cortical thickness were not affected by supplementation with phytase, 
strontium, or both (Table 3.5). At week 5, 3-point bending test on femurs 
showed a decrease (p = 0.04) in displacement at maximum load and a 
marginal increase (p = 0.09) of approximately 10% in bending rigidity. 
Strontium supplementation had a marginal effect (p = 0.09) on energy to 
break.  
 
 
3.5  Discussion 
 
In this study we used three-point bending to determine whole bone strength 
to failure. Bending moment was not different among treatment groups; 
however, phytase supplementation had a marginal effect (p = 0.09) on 
bending rigidity. Phytase supplementation increased bending rigidity 
approximately 10%, which agreed with a previous study (29). This non-
significant increase in bending rigidity was not due to animals being larger as 
evidenced by the growth performance results and suggests that this change in 
bone function was a treatment effect. Furthermore, the final status of assayed 
P-response measures was similar between pigs fed BD and BD + phytase. 
Therefore, any benefit of supplemental phytase was unlikely a response to an 
increase in P availability, especially in the 0.35% P-adequate diet implemented 
in this study.  
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Table 3.5 Femur geometrical and biomechanical measurements after 5 weeks of the feeding trial1 
1 Values are means, n = 5 
2 Phy, phytase; Sr, strontium 
  Treatment      
Phytase, U/kg 0 3500 0 3500  Main effect, p-value 
Strontium, mg/kg 0 0 50 50 SEM Phytase Strontium Phy x Sr2 
Geometry          
Weight, g 126.3 127.7 125.1 131.3 7.9 0.4 0.8 0.6 
Length, mm 125.7 126.5 125.4 126.7 2.9 0.5 1.0 0.9 
Width (a), mm 17.3 17.1 17.2 18.1 1.3 0.6 0.5 0.4 
Height (b), mm 16.9 17.2 17.9 18.2 1.8 0.7 0.3 0.9 
Cortical thickness (ct. th.ml), mm 2.8 2.5 2.8 3.1 0.6 1.0 0.3 0.2 
Cortical thickness (ct. th.ap), mm 3.5 3.6 3.6 3.7 0.6 0.9 0.7 1.0 
         
Moment of Inertia, mm4         
Iap 3770 3710 4170 4780 1180 0.7 0.3 0.6 
Iml 3680 3390 3580 4480 1440 0.6 0.4 0.3 
Ellipticity index (Iap/ Iml) 1.0 1.1 1.2 1.1 0.2 1.0 0.8 0.4 
         
Whole Bone Mechanics          
Maximum displacement, mm 5.7 5.0 6.2 5.3 0.7 0.04 0.3 0.7 
Breaking energy, J 5.5 4.3 5.9 5.7 0.9 0.1 0.06 0.3 
Bending moment, N-m 25.5 25.8 24.0 27.0 2.9 0.3 0.9 0.4 
Bending rigidity, N-m2 2.2 2.4 2.1 2.4 0.3 0.09 0.9 0.7 
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The bone cross sectional geometry did not differ with phytase 
supplementation, and thus did not contribute to the observed increase in 
bending rigidity. Therefore, changes in material properties, such as femur 
mineral content, may be responsible for the observed non-significant increase 
in femur bending rigidity. This hypothesis is supported by DXA analysis, 
which showed an increase (p < 0.05) in BMC with phytase supplementation at 
week 5.  
 
The basal corn-soybean meal diet used in this study contained approximately 
7 mg/kg of strontium as determined by ICP-AES (Inductively Coupled 
Plasma - Atomic Emission Spectrometer) analysis. Strontium was 
supplemented at 50 mg/kg (0.005 percent) in the diet, which is approximately 
7 times greater than the concentration in a corn-soybean meal diet for pigs. 
Yet, a 50 mg/kg dose is conservative when compared to the reported effective 
anti-osteoporotic doses of strontium, such as 2 g/day in humans, 625 
mg/kg/day in rats, and 750 mg/day in monkeys (74-76). The low-level of Sr 
used in this study may account for the responses observed on whole bone 
strength and geometry. However, a 50 mg/kg dose of strontium was reported 
to increase (p < 0.05) Sr mineral concentration in femur and metatarsal (29). 
Therefore, this dose seems to be effective in increasing plasma and bone 
mineral concentration, yet may not lead to significant functional changes in 
the femur at 5 weeks. 
 
At 10 weeks, strontium supplementation had a main effect (p < 0.05) on bone 
mineral density, however caution should be given in interpreting DXA results 
in strontium studies. DXA analysis typically overestimates BMC and BMD by 
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10% in animals treated with strontium (77,78). This is due to the higher atomic 
number of strontium (Sr, Z = 38) compared to calcium (Ca, Z = 20). Any 
observed increase in BMC and BMD is primarily a physical effect due to the 
increased attenuation of X-rays when some of the calcium in bone is replaced 
by strontium (79). Therefore, DXA analysis may overestimate increases in 
bone density, because Sr is denser than Ca, and cannot be interpreted as a 
measure of mineralization in animals supplemented with strontium. At 5 
weeks, BMD was not elevated in animals supplemented with strontium, 
which does not agree with a previous strontium supplementation study (29). 
Nonetheless, an increase in BMD at 5 or 10 weeks is most likely due to the 
presence of strontium and does reflect an increase in bone mineralization. 
Concurrent geometric and biomechanical analysis of femurs at 10 weeks is 
necessary to better determine the benefits of low-dose strontium 
supplementation on skeletal tissue in swine.  
 
Overall, phytase supplementation had a marginal effect on bone rigidity. In 
the previous study (Chapter 2), we observed a more robust effect of 
supplemental phytase on femur bending rigidity (p < 0.05) as well as slight 
changes in femur geometry. Two differences between this study and the 
previous study may account for the discrepancy in the observed results. These 
include the length of the feeding trial and time of mechanical testing. The 
study in Chapter 2 was a feeding trial for 6-weeks, while this study was 
conducted for a total of 5-weeks. The additional week of growth, particularly 
when the swine are at their greatest feed: gain ratio. Furthermore, in the 
Chapter 2 study three-point bending was performed within a week after 
bones were collected compared to a year later in this study. It seems likely that 
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the delay in testing may have compromised the bones and led to differences in 
observed bone properties between studies.  
 
Strontium supplementation had no significant impact on femur 
characteristics, which may due to a combination of factors such as the 
duration of the feeding trial and the low-dose supplemented in the diet. 
Further examination of femurs from swine at 10 weeks of the feeding trial 
with three-point bending will demonstrate any impact this supplement has on 
whole bone strength. In addition, investigating strontium supplementation at 
a higher dose may better demonstrate the ability of this mineral to impact the 
skeletal system. In summary, the impact and magnitude of dietary phytase 
and strontium supplementation on bone is still inconclusive.  
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CHAPTER FOUR 
THE IMPACT OF DIETARY PHYTASE SUPPLEMENTATION ON 
FEMURS OF MICE FED A PHYTATE-FREE NUTRITENT ADEQUATE 
DIET 
 
4.1  Abstract 
 
Phytase, an acid phosphatase, has been shown to improve skeletal properties 
in swine, poultry, and rats when supplemented in a phosphorus deficient diet. 
This study was designed to test if dietary microbial phytase improved bone 
properties when supplemented in a nutrient adequate, phytate-free diet, in 
wild-type (WT) and superoxide dismutase knockout (SOD1 -/-; Cu, Zn-SOD; 
EC 1.15.1.1) mice. The SOD1 -/- mice are a mouse model of reduced skeletal 
integrity, such as maximum breaking moment and bending rigidity. A total of 
38 mixed gender WT mice were examined and fed a Torula yeast and sucrose 
diet, BD, (n = 17, seven females and ten males) or BD + phytase (n = 21, 
thirteen females and eight males). A total of 17 mice SOD1 -/- were fed BD (n 
= 7, three females and four males) or BD + phytase (n = 10, five females and 
five males). For both WT and SOD1 -/- mice, littermates were split between 
dietary treatments. Phytase supplementation did not alter bone parameters as 
measured with three-point bending or body weight in the WT or SOD1 -/- 
mouse. A gender difference was observed in SOD1 -/- mice with females 
having a greater (p < 0.05) bending moment and (p = 0.09) maximum bending 
moment, which was not a consequence of increase cross sectional size. 
Overall, phytase seemed to require the presence of its intrinsic substrate, 
phytate, to positively impact skeletal tissue in the growing mice.   
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4.2  Introduction 
 
The two previous swine studies examined the impact of phytase 
supplementation on whole bone strength early in life to determine if phytase 
can be used to reduce musculoskeletal disease. This study was conducted to 
better understand the mechanism of phytase and determine whether phytase, 
the enzyme, or the products of phytate degradation are responsible for the 
observed effects on bone biomechanics. We investigated the impact of dietary 
phytase supplementation on whole bone strength in a phytate-free Torula 
yeast and sucrose diet in WT and SOD1 -/- mice. Positive results on skeletal 
parameters would suggest that phytase impacts bone properties via a non-
phytate mechanism, and therefore the phosphorus and minerals released from 
phytate degradation are not responsible for the beneficial effects on skeletal 
tissue. Furthermore, phytase supplementation in SOD1 -/- mice was 
examined to demonstrate if phytase can “rescue” the compromised bones of 
these transgenic mice. SOD1 catalyzes the dismutation of superoxide, a 
common free radical in the body, to oxygen and hydrogen peroxides, 
classifying it as a cellular antioxidant (80). Previous studies have 
demonstrated that SOD1 -/- mice have compromised skeletal tissue, such as a 
decrease in bending moment and rigidity, compared to WT mice (81).  
Therefore, positive results would further demonstrate the ability of dietary 
phytase to improve bone properties without phytate and also restore 
compromised bone.  
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4.3  Methods 
 
4.3.1  Experimental design 
 
WT and SOD1 −/− (superoxide dismutase; Cu, Zn-SOD; EC 1.15.1.1) mice 
were derived from 129/SVJ×C57BL/6 lines and provided by Dr Y. S. Ho, 
Wayne State University (Detroit, MI, U.S.A.) (82). All experiments were 
approved by the Institutional Animal Care and Use Committee at Cornell 
University and conducted in accordance with NIH (National Institutes of 
Health) Guidelines for Animal Care. Mice were housed in shoebox cages in a 
room at a constant temperature (22 °C) with a 12 h light/dark cycle and were 
given free access to food and distilled water.  
 
Wild-type mice were weaned at 3 weeks of age and were derived from one of 
two females (WT) mated to the same male (WT) to reduce genetic variability. 
At weaning, pups were fed ad libitum a Torula yeast sucrose based diet (BD) 
or BD supplemented with microbial phytase (BD + phytase, 3500U/kg, 
OptiPhos, JBS United, Sheridan, IN) for 12 weeks. SOD1 -/- mice were 
weaned at 3 weeks of age and were derived from one of two females (SOD 1-
/+) mated to the same male (SOD1 -/-). Pups were genotyped after weaning 
and in the interim were fed BD. At 4 weeks of age SOD1 -/- pups were fed ad 
libitum the same BD or BD + phytase as WT mice and remained on these diets 
for 12 weeks. All other minerals and nutrients were adequate in the diet.  A 
total of 38 mixed gender WT mice were examined and fed BD (n = 17, 7 
females and 10 males) or BD + phytase (n = 21, 13 females and 8 males).  Due 
to the breeding constraints of the transgenic SOD1 mice, a reduced number of 
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mice were examined. A total of 17 mice SOD1 -/- were fed BD (n = 7, 3 
females and 4 males) or BD + phytase (n = 10, 5 females and 5 males). For both 
WT and SOD1 -/- mice littermates were split between dietary treatments.  
 
Body weights were measured weekly using a digital scale. At the end of 12 
weeks, animals were killed by CO2 inhalation as approved by the IACUC at 
Cornell University and conducted in accordance with NIH Guidelines for 
Animal Care. The right femur from each animal was collected for mechanical 
testing. 
 
4.3.2  Whole bone strength  
 
Immediately after sacrifice, femurs were excised and muscle and tissue were 
removed. Femurs were placed in freezer bags at -20°C until mechanical testing 
could be performed. Three-point bending was accomplished using a 
Servohydraulic testing machine (858 MiniBionix, MTS Systems, Eden Prairie, 
MN). Loading rate was set at 0.1 mm/s and span length was 6mm.   
 
4.4  Results 
 
4.4.1  Body weight 
 
Phytase supplementation did not alter the body weights of WT or SOD1 -/- 
mice during the 12-week feeding trial (Table 4.1 and 4.2). 
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Table 4.1 Body weights of WT mice during the 12-week feeding trial1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Values are means 
2 BD, n =10; Phytase, n = 8  
3 BD, n = 7; Phytase, n = 13  
4 BD, basal diet
Gender Male2 Female3  Main effect, p-value 
Diet BD4 Phytase BD4 Phytase SEM Diet Gender Diet x Gender 
Wk 0 10.2 10.3 9.9 9.0 0.7 0.2 0.04 0.2 
Wk 1 14.5 15.8 13.5 13.0 0.7 0.2 < 0.001 0.02 
Wk 2 19.8 20.1 16.1 15.9 1.1 1.0 < 0.001 0.6 
Wk 3 22.3 22.5 18.3 17.5 1.1 0.6 < 0.001 0.4 
Wk 4 24.0 24.3 20.1 19.0 1.0 0.5 < 0.001 0.2 
Wk 5 25.2 25.5 21.6 20.6 1.1 0.5 < 0.001 0.3 
Wk 6 26.5 26.8 22.2 21.7 1.3 0.9 < 0.001 0.6 
Wk 7 27.4 27.7 23.3 22.6 1.2 0.8 < 0.001 0.5 
Wk 8 28.6 28.8 24.3 23.5 1.4 0.7 < 0.001 0.5 
Wk 9 29.5 29.9 24.1 23.7 1.6 1.0 < 0.001 0.6 
Wk 10 29.7 30.1 24.9 24.3 1.5 0.9 < 0.001 0.6 
Wk 11 30.3 30.7 25.3 24.9 1.6 1.0 < 0.001 0.6 
Wk 12 31.0 30.9 26.0 26.1 1.9 1.0 < 0.001 0.9 
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Table 4.2 Body weights of SOD1 -/- mice during the 12-week feeding trial1 
1 Values are means 
2 BD, n = 4; Phytase, n = 5  
3 BD, n = 3; Phytase, n = 5  
4 BD, basal diet 
Gender Male2 Female3  Main effect, p-value 
Diet BD4 Phytase BD4 Phytase SEM Diet Gender Diet x Gender 
Wk 0 14.4 13.1 12.6 11.3 2.2 0.3 0.1 1.0 
Wk 1 16.4 14.8 14.3 13.8 2.1 0.3 0.2 0.6 
Wk 2 19.5 17.4 17.5 16.6 2.7 0.3 0.3 0.6 
Wk 3 22.4 20.5 19.1 18.9 3.2 0.6 0.2 0.6 
Wk 4 23.2 22.7 19.9 20.5 3.2 1.0 0.1 0.7 
Wk 5 23.9 23.7 20.7 21.6 3.3 0.8 1.0 0.7 
Wk 6 24.0 24.30 21.1 22.1 3.3 0.7 0.1 0.8 
Wk 7 25.2 25.2 22.7 24.1 3.9 0.7 0.4 0.7 
Wk 8 26.3 26.4 24.6 24.8 3.3 0.9 0.4 1.0 
Wk 9 27.7 26.9 25.9 26.3 3.5 0.9 0.5 0.8 
Wk 10 28.5 27.2 27.1 26.6 3.3 0.6 0.5 0.8 
Wk 11 28.6 28.0 28.1 27.7 3.7 0.8 0.8 1.0 
Wk 12 29.5 27.6 28.0 29.2 3.5 0.8 1.0 0.4 
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4.4.2  Whole bone strength 
 
Femurs were tested with three-point bending and were loaded to failure. 
Phytase supplementation did not affect maximum bending moment rigidity, 
bending rigidity, or displacement in the WT or SOD1 -/- mice (Table 4.3 and 
4.4). In addition, we did not observe any evidence of decreased skeletal 
characteristics in the SOD1 -/- mice with the 3-point bending test as 
previously reported.  However, we did observe significant gender differences 
in SOD1 -/- mice. Bending rigidity significantly increased (p < 0.05) and 
bending moment marginally increased (p = 0.09) in female SOD1 -/- mice.  
 
4.5  Discussion 
 
Phytase supplementation did not alter body weight or whole bone strength as 
measured by three-point bending in the WT or SOD -/- mouse. Therefore, it 
appears that phytase requires phytate to impact skeletal tissue, at least in the 
mouse. However, we did observe a gender difference in SOD1 -/- mice in 
bending rigidity and bending moment. This was not due to the female mice 
having an increased femoral cross sectional size. Typically, male mice, 
partially due to greater size, exhibit higher skeletal parameters, such as bone 
mineral mass fraction, bone density, and strength (83,84). Therefore, the loss of 
superoxide dismutase seems to benefit the skeletal tissue in female mice in this 
study, but these results may be limited due to the small sample size of female 
SOD1 -/- mice used in each dietary treatment (BD, n = 4 females and BD + 
phytase, n = 3 females).  
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Table 4.3 Biomechanical results from three-point bending on WT femurs1 
1 Values are means 
2 BD, n =10; Phytase, n = 8  
3 BD, n = 7; Phytase, n = 13  
4 BD, basal diet 
Gender Male2 Female3  Main effect, p-value 
Diet BD4 Phytase BD4 Phytase SEM Diet Gender Diet x Gender 
Maximum Bending Moment, N-mm 43.8 45.9 43.6 44.6 3.6 0.4 0.7 0.8 
Bending Rigidity, N-mm2 1.2 1.3 1.3 1.3 0.2 0.4 0.5 0.3 
Difference in Displacement, mm 0.4 0.3 0.4 0.3 0.2 0.2 0.6 0.6 
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Table 4.4 Biomechanical results from three-point bending on SOD1 -/- femurs1 
1 Values are means 
2 BD, n = 4; Phytase, n = 5  
3 BD, n = 3; Phytase, n = 5  
4 BD, basal diet
Gender Male2 Female3  Main effect, p-value 
Diet BD4 Phytase BD4 Phytase SEM Diet Gender Diet x Gender 
Maximum Bending Moment, N-mm 39.3 38.5 50.5 45.2 9.9 0.6 0.09 0.7 
Bending Rigidity, N-mm2 1.2 1.0 1.7 1.4 0.4 0.2 0.02 0.9 
Difference in Displacement, mm 0.3 0.3 0.1 0.3 0.1 0.2 0.1 0.2 
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Interestingly, we did not observe any differences in whole bone strength or 
difference in displacement in the transgenic mice compared to WT mice. 
Previous studies have demonstrated a 41% decrease in bending moment and a 
38% decrease in bending rigidity in SOD -/- mice compared to WT mice (81). 
To determine the true skeletal integrity of the SOD -/- mice, it is necessary to 
conduct re-examination of the whole bone strength of these transgenic mice as 
well as an increase in sample size of each sex to confirm the gender difference 
observed in this experiment.  
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CHAPTER FIVE 
CONCLUSION 
 
5.1. Phytase Supplementation in Swine and Mouse 
 
We demonstrated the potential of dietary phytase to improve whole bone 
strength, specifically bending rigidity, when supplemented in a high 
phosphorus diet in young pigs. These results agree with previous findings 
and suggest that skeletal tissue may benefit from the presence of phytase that 
is not exclusively due to the phosphorus release from the degradation of 
phytate (29). However, our second swine study (Chapter Three) examined 
phytase and strontium supplementation over a 10-week feeding period and 
improvements in skeletal parameters and whole bone strength were not as 
robust as those observed in the first study (Chapter Two). This discrepancy 
between the two studies may be due to a few obvious differences between the 
two studies as discussed in Chapter Three, and include the length of the 
feeding trial, the season the study was conducted, and the time of mechanical 
testing. Therefore, the use of supplemental phytase in young animals as a 
means to prevent musculoskeletal diseases requires further investigation. 
 
 
Furthermore, the dietary phytase feeding trial in the mouse demonstrated that 
phytase-mediated bone improvements require the presence of phytate, the 
intrinsic substrate of phytase, in the diet. We did not observe any 
improvements in bone parameters in the compromised skeleton of SOD1 -/- 
mice with phytase supplementation.  
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5.2 Possible Mechanism for Phytase in Improving Whole Bone Strength 
 
The presence of phytase and phytate in the diet increases mineral 
bioavailability. Minerals liberated from phytate may improve bone health 
through their interactions with metalloenzymes involved in bone metabolism, 
such as alkaline phosphatase (AKP) and tartrate-resistant acid phosphatase 
(TRAP). For example, zinc is an essential trace mineral for animal 
development, as demonstrated by reduced bone growth in animal fed diets 
deprived of zinc (85). Microbial phytase-fed piglets increased plasma and 
bone zinc concentrations. Herein, we observed similar increases (p < 0.05) in 
both of these parameters (86). AKP is found on the surface of osteoblasts and 
is marker for bone formation. AKP is a Zn-metalloenzyme and contains two 
Zn active centers necessary for its enzymatic activity, althougth the precise 
biochemical function of this enzyme is still unclear (87). Experiments 
investigating levels of dietary Zn on bone health have shown that increases in 
this element are accompanied by increases in AKP and decreases in bone 
resorption (88,89). Therefore, dietary Zn appears to adjust the bone 
remodeling cycle to favor bone mass accumulation. However, there are 
conflicting reports in regards to the impact of zinc on AKP and bone health, 
which may be due to differences in the age of animal used in studies and 
discrepancies between in vitro and in vivo responses (88,90).  
 
TRAP, an iron dependent phosphatase, is another example of a 
metalloenzyme involved bone metabolism that may be affected by an increase 
in dietary iron. TRAP is secreted by osteoclasts to resorb the bone matrix and 
allow for new mineralization by osteoblasts. TRAP contains a diferric center at 
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its active site that conveys catalytic activity of the enzyme (91,92). In addition, 
post-transcriptional control of the TRAP gene may also be regulated by iron 
(93).  Therefore, increases in dietary iron may directly impact TRAP and alter 
bone metabolism in a positive manner. Overall, the participation of 
metalloenzymes in bone growth and remodeling may respond to changes in 
their regulatory minerals and influence skeletal tissue dynamics. We 
hypothesize that dietary phytase impacts skeletal tissue via liberation of bone-
affecting metoalloenzyme minerals from phytate, creating a novel mineral 
environment that may be advantageous during skeletal tissue development.   
 
 
The release of inositol phosphates from phytate degradation is another 
possible mechanism for phytase to improve whole bone strength. Inositol 
phosphates are important cellular signaling molecules and are involved in a 
numerous pathways. The increase in inositol derivative from phytate 
degradation may hyperactivate a pathway to improve bone health. For 
example, the inositol-1-4-5 phosphates pathway is important for intracellular 
calcium release, a prerequisite for the expression of bone matrix proteins, such 
as collagen and fibronectin (69,70). The presence of inostiol phosphates may 
further activate such an inositol pathway, improving the material composition 
of bone, thus improving whole bone strength.  
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5.3 Future Direction 
 
Additional studies should extend the feeding trial to determine if 
improvements in bone by phytase supplementation are sustainable as the 
animals mature. Also, it may be important to examine dietary phytase 
supplementation in older animals, or an osteoporotic animal model in order to 
identify the skeletal growth period when supplementation is most effective. 
Overall, it is critically important that we gain better insight into the nutrition 
requirements for the optimal growth and maintenance in order to develop 
simple diet-based strategies that will favor optimal skeletal development and 
growth, leading to better bone health in the animals and humans.   
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